vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.
PRA GROUP INC is the larger business by last-quarter revenue ($333.4M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). PRA GROUP INC runs the higher net margin — 17.0% vs 8.3%, a 8.7% gap on every dollar of revenue. On growth, PRA GROUP INC posted the faster year-over-year revenue change (13.7% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-90.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 14.2%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.
COLL vs PRAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $333.4M |
| Net Profit | $17.0M | $56.5M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 37.7% |
| Net Margin | 8.3% | 17.0% |
| Revenue YoY | 12.9% | 13.7% |
| Net Profit YoY | 35.3% | 206.3% |
| EPS (diluted) | $0.48 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $333.4M | ||
| Q3 25 | $209.4M | $311.1M | ||
| Q2 25 | $188.0M | $287.7M | ||
| Q1 25 | $177.8M | $269.6M | ||
| Q4 24 | $181.9M | $293.2M | ||
| Q3 24 | $159.3M | $281.5M | ||
| Q2 24 | $145.3M | $284.2M | ||
| Q1 24 | $144.9M | $255.6M |
| Q4 25 | $17.0M | $56.5M | ||
| Q3 25 | $31.5M | $-407.7M | ||
| Q2 25 | $12.0M | $42.4M | ||
| Q1 25 | $2.4M | $3.7M | ||
| Q4 24 | $12.5M | $18.5M | ||
| Q3 24 | $9.3M | $27.2M | ||
| Q2 24 | $19.6M | $21.5M | ||
| Q1 24 | $27.7M | $3.5M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 37.7% | ||
| Q3 25 | 29.7% | -101.4% | ||
| Q2 25 | 18.7% | 29.6% | ||
| Q1 25 | 12.2% | 27.7% | ||
| Q4 24 | 20.9% | 32.1% | ||
| Q3 24 | 21.9% | 32.0% | ||
| Q2 24 | 32.7% | 31.4% | ||
| Q1 24 | 34.1% | 26.0% |
| Q4 25 | 8.3% | 17.0% | ||
| Q3 25 | 15.0% | -131.0% | ||
| Q2 25 | 6.4% | 14.7% | ||
| Q1 25 | 1.4% | 1.4% | ||
| Q4 24 | 6.9% | 6.3% | ||
| Q3 24 | 5.9% | 9.6% | ||
| Q2 24 | 13.5% | 7.6% | ||
| Q1 24 | 19.1% | 1.4% |
| Q4 25 | $0.48 | $1.47 | ||
| Q3 25 | $0.84 | $-10.43 | ||
| Q2 25 | $0.34 | $1.08 | ||
| Q1 25 | $0.07 | $0.09 | ||
| Q4 24 | $0.36 | $0.47 | ||
| Q3 24 | $0.27 | $0.69 | ||
| Q2 24 | $0.52 | $0.54 | ||
| Q1 24 | $0.71 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $104.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $979.9M |
| Total Assets | $1.7B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $104.4M | ||
| Q3 25 | $285.9M | $107.5M | ||
| Q2 25 | $222.2M | $131.6M | ||
| Q1 25 | $197.8M | $128.7M | ||
| Q4 24 | $162.8M | $105.9M | ||
| Q3 24 | $120.0M | $141.1M | ||
| Q2 24 | $271.6M | $118.9M | ||
| Q1 24 | $318.0M | $108.1M |
| Q4 25 | $301.7M | $979.9M | ||
| Q3 25 | $274.8M | $928.5M | ||
| Q2 25 | $232.2M | $1.3B | ||
| Q1 25 | $234.4M | $1.2B | ||
| Q4 24 | $228.8M | $1.1B | ||
| Q3 24 | $234.3M | $1.2B | ||
| Q2 24 | $216.6M | $1.1B | ||
| Q1 24 | $222.2M | $1.1B |
| Q4 25 | $1.7B | $5.1B | ||
| Q3 25 | $1.6B | $5.0B | ||
| Q2 25 | $1.6B | $5.4B | ||
| Q1 25 | $1.6B | $5.1B | ||
| Q4 24 | $1.7B | $4.9B | ||
| Q3 24 | $1.6B | $4.9B | ||
| Q2 24 | $1.1B | $4.7B | ||
| Q1 24 | $1.1B | $4.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-85.5M |
| Free Cash FlowOCF − Capex | $122.4M | $-90.4M |
| FCF MarginFCF / Revenue | 59.6% | -27.1% |
| Capex IntensityCapex / Revenue | 0.3% | 1.4% |
| Cash ConversionOCF / Net Profit | 7.25× | -1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-169.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-85.5M | ||
| Q3 25 | $78.4M | $-10.1M | ||
| Q2 25 | $72.4M | $-12.9M | ||
| Q1 25 | $55.4M | $-52.6M | ||
| Q4 24 | $84.6M | $-94.6M | ||
| Q3 24 | $-9.0M | $-35.0M | ||
| Q2 24 | $67.4M | $-29.5M | ||
| Q1 24 | $61.9M | $-73.0M |
| Q4 25 | $122.4M | $-90.4M | ||
| Q3 25 | $78.3M | $-11.3M | ||
| Q2 25 | $72.4M | $-14.2M | ||
| Q1 25 | $54.6M | $-53.5M | ||
| Q4 24 | $84.1M | $-98.6M | ||
| Q3 24 | $-9.2M | $-36.1M | ||
| Q2 24 | $67.1M | $-30.8M | ||
| Q1 24 | $61.4M | $-73.5M |
| Q4 25 | 59.6% | -27.1% | ||
| Q3 25 | 37.4% | -3.6% | ||
| Q2 25 | 38.5% | -4.9% | ||
| Q1 25 | 30.7% | -19.8% | ||
| Q4 24 | 46.2% | -33.6% | ||
| Q3 24 | -5.8% | -12.8% | ||
| Q2 24 | 46.2% | -10.8% | ||
| Q1 24 | 42.3% | -28.8% |
| Q4 25 | 0.3% | 1.4% | ||
| Q3 25 | 0.1% | 0.4% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.3% | 1.4% | ||
| Q3 24 | 0.2% | 0.4% | ||
| Q2 24 | 0.2% | 0.5% | ||
| Q1 24 | 0.4% | 0.2% |
| Q4 25 | 7.25× | -1.51× | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | -0.30× | ||
| Q1 25 | 22.92× | -14.37× | ||
| Q4 24 | 6.75× | -5.13× | ||
| Q3 24 | -0.96× | -1.29× | ||
| Q2 24 | 3.44× | -1.37× | ||
| Q1 24 | 2.23× | -21.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
PRAA
| GB | $170.1M | 51% |
| Other | $163.3M | 49% |
